In the TRIUMPH-1 trial, the highest retatrutide dose was associated with an average 28.3% reduction in body weight at 80 weeks, according to results…
A trial result and a biohacker’s account are not equivalent evidence. The Retatrutide research peptide is attracting attention in clinical literature…
Choose which cookies you allow. You can change your choice at any time using the cookie settings button in the bottom left of the page.
Required for the site to function. They enable basic navigation, security, your basket, checkout, and account login. The site cannot operate without these.
Enable enhanced functionality and personalisation, such as remembering your preferences or live chat widgets.
Help us understand how visitors use the site by collecting and reporting information anonymously. Includes Google Analytics.
Used to track visitors across websites and measure advertising. Includes Google Ads, Meta Pixel, and similar services. These are never set without your consent.